First, it was retrospective, which means it relied on patients recalling their experiences months laterthis is far less reliable than a controlled, prospective study
Healthcare providers should discuss the use of semaglutide with patients who have thyroid issues
If no serious pathology is found, and the bleeding is not heavy or persistent, a doctor may allow continued semaglutide use with monitoring
Eligibility Requirements According to the company's published Terms, you may qualify for a potential refund if you are a new customer who completed the initial intake assessment with accurate weight reporting, took weekly doses as directed by your clinician for 16 consecutive weeks (that is 16 total doses), were not prescribed other weight loss medications in the past 12 months, and failed to lose 10% of your baseline weight after completing those 16 weeks
On average, patients treated for obesity lost 8.4 % of their original body weight while on the medication, compared with a 4.4 % reduction among those treated for T2DM